Spots Global Cancer Trial Database for transplantation
Every month we try and update this database with for transplantation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| In Vitro Study of Peripheral Blood Mononuclear Cell Function in Healthy Individuals and Patients | NCT00342485 | Cell Function | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) | NCT01198704 | Hepatocellular ... Liver Cirrhosis Evidence of Liv... | search of facto... | 18 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| Bortezomib Plus Rituximab for EBV+ PTLD | NCT01058239 | Post-transplant... Solid Organ Tra... Stem Cell Trans... Epstein Barr Vi... | bortezomib rituximab | 18 Years - | Massachusetts General Hospital | |
| Partial Liver Segment 2/3 Transplantation Study | NCT02215889 | Colorectal Canc... | Liver transplan... | 18 Years - | Oslo University Hospital | |
| Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment | NCT03706625 | Non Hodgkin Lym... Non Small Cell ... Glioma | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection | NCT00001701 | Cryptococcosis | - | National Institutes of Health Clinical Center (CC) | ||
| Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
| Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis | NCT04217356 | Myelofibrosis High-Risk Cance... Bone Marrow Can... | Hematopoietic s... Ruxolitinib Hydroxyurea | 18 Years - 70 Years | University Health Network, Toronto | |
| A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma | NCT00636311 | Hodgkin Disease | Ifosfamide, Gem... Bortezomib + IG... | 18 Years - 65 Years | Istituto Clinico Humanitas | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| Assessment of the Effects of Pressors on Graft Blood Flow After Free Tissue Transfer Surgery | NCT01418118 | Oral Cancer Head and Neck C... Free Flap Hypotension | Epinephrine Norepinephrine Dobutamine Dopexamine | 17 Years - | Oxford University Hospitals NHS Trust | |
| A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies | NCT02386332 | Hematologic Mal... | transplantation | 18 Years - 55 Years | Instituto de Investigacion Sanitaria La Fe | |
| Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study | NCT00156858 | Hematologic Mal... | intravenous bus... | - 70 Years | AHS Cancer Control Alberta | |
| Phase II Study of 5-azacytidine Maintenance After Transplant for AML or MDS | NCT02204020 | Acute Myeloid L... Myelodysplastic... | 5-azacytidine (... | 18 Years - | University of Pittsburgh | |
| Liver Transplantation After ex Vivo Liver Perfusion | NCT05951231 | Liver Transplan... Transplant; Fai... Transplant Dysf... Transplant; Com... Transplant Liver Metastase... Liver Cancer | Liver transplan... | 18 Years - 100 Years | Oslo University Hospital | |
| Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY | NCT00809276 | Lymphoma Multiple Myelom... Leukemia Myelodysplastic... | Busulfan, Fluda... | - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) | NCT01379209 | Graft Versus Ho... | RGI-2001 Calcineurin Inh... Allogeneic Hema... Conditioning Re... Allogeneic Bone... Methotrexate Mofetil Mycophe... sirolimus | 18 Years - | Regimmune Corporation | |
| Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection | NCT00001701 | Cryptococcosis | - | National Institutes of Health Clinical Center (CC) | ||
| Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults | NCT04179929 | Acute Lymphobla... | Pediatric-type ... allogeneic HSCT | 18 Years - 60 Years | PETHEMA Foundation | |
| Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. | NCT02006225 | Autologous Stem... | Plerixafor | - 30 Years | Tel-Aviv Sourasky Medical Center | |
| Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma | NCT06060080 | Lymphoma Multiple Myelom... | pegylated recom... | 18 Years - 65 Years | Chongqing University Cancer Hospital | |
| INvestigational Study Into Transplantation of the Uterus | NCT04244409 | Mayer-Rokitansk... Asherson's Synd... Postpartum Hemo... Cervical Cancer | 24 Years - 38 Years | Womb Transplant UK | ||
| Partial Liver Segment 2/3 Transplantation Study | NCT02215889 | Colorectal Canc... | Liver transplan... | 18 Years - | Oslo University Hospital | |
| Pethema Multiple Myeloma 2000 | NCT00560053 | Multiple Myelom... | Alternating che... Autologous Tran... Maintenance Second transpla... ALOGENIC MINI T... | - 69 Years | PETHEMA Foundation | |
| Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | NCT01010880 | Multiple Myelom... | BKT140 | 16 Years - 65 Years | Biokine Therapeutics Ltd | |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) | NCT01198704 | Hepatocellular ... Liver Cirrhosis Evidence of Liv... | search of facto... | 18 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT | NCT04789434 | Lymphoma, Large... Transplantation Chemotherapy | PD-1 Inhibitor ... | 18 Years - 65 Years | Ruijin Hospital | |
| Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma | NCT06060080 | Lymphoma Multiple Myelom... | pegylated recom... | 18 Years - 65 Years | Chongqing University Cancer Hospital | |
| Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment | NCT03706625 | Non Hodgkin Lym... Non Small Cell ... Glioma | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer | NCT00001193 | Breast Neoplasm... Neoplasm Metast... | high dose melph... | - | National Institutes of Health Clinical Center (CC) | |
| In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients | NCT00001336 | Immunologic Def... Leukemia Lymphoma Neoplasm | - | National Institutes of Health Clinical Center (CC) | ||
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells | NCT00692926 | MDS Anemia, Aplasti... Inborn Errors o... Congenital Marr... Congenital Immu... | ALDHbr Umbilica... | - 55 Years | Duke University | |
| A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). | NCT00838357 | Lymphoma (Non-H... Hodgkin's Disea... Front Line Mobi... Transplantation | Generic = Pleri... | 18 Years - | Sanofi | |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) | NCT01198704 | Hepatocellular ... Liver Cirrhosis Evidence of Liv... | search of facto... | 18 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients | NCT05171335 | Hepatocellular ... | Lenvatinib Transcatheter A... | 18 Years - | The Methodist Hospital Research Institute | |
| A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). | NCT00838357 | Lymphoma (Non-H... Hodgkin's Disea... Front Line Mobi... Transplantation | Generic = Pleri... | 18 Years - | Sanofi | |
| Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection | NCT00001701 | Cryptococcosis | - | National Institutes of Health Clinical Center (CC) | ||
| PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT | NCT04789434 | Lymphoma, Large... Transplantation Chemotherapy | PD-1 Inhibitor ... | 18 Years - 65 Years | Ruijin Hospital | |
| Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients. | NCT02006225 | Autologous Stem... | Plerixafor | - 30 Years | Tel-Aviv Sourasky Medical Center | |
| A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer | NCT00001193 | Breast Neoplasm... Neoplasm Metast... | high dose melph... | - | National Institutes of Health Clinical Center (CC) | |
| Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults | NCT04179929 | Acute Lymphobla... | Pediatric-type ... allogeneic HSCT | 18 Years - 60 Years | PETHEMA Foundation | |
| Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation | NCT01596699 | Myeloid Maligna... Bone Marrow Fai... Transfusion-dep... Congenital Immu... Metabolic Disea... Severe Immune D... | Alemtuzumab Busulfan Fludarabine Clofarabine | 3 Months - 30 Years | University of California, San Francisco | |
| Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) | NCT01198704 | Hepatocellular ... Liver Cirrhosis Evidence of Liv... | search of facto... | 18 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML) | NCT01468467 | Leukemia, Myelo... | AC220 | 18 Years - | Daiichi Sankyo | |
| Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk | NCT02757989 | MDS | transplantation | 18 Years - 69 Years | Groupe Francophone des Myelodysplasies | |
| Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM) | NCT02703779 | Multiple Myelom... | Bortezomib Granulocyte col... Mozobil | 18 Years - | University of Kansas Medical Center | |
| In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients | NCT00001336 | Immunologic Def... Leukemia Lymphoma Neoplasm | - | National Institutes of Health Clinical Center (CC) | ||
| Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk | NCT02757989 | MDS | transplantation | 18 Years - 69 Years | Groupe Francophone des Myelodysplasies | |
| Efficacy and Safety of PEG-rhG-CSF Injection for Neutrophil Reconstitution Following AHSCT in Lymphoma/Multiple Myeloma | NCT06060080 | Lymphoma Multiple Myelom... | pegylated recom... | 18 Years - 65 Years | Chongqing University Cancer Hospital | |
| Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy | NCT00796562 | MDS Leukemias Lymphomas | Busulfan Cyclophosphamid... Total body irra... | 6 Months - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome Low Risk | NCT02757989 | MDS | transplantation | 18 Years - 69 Years | Groupe Francophone des Myelodysplasies |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
